{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_1761c57e466f6136351e8613a41f32baae69703af73cfded579937db417ab98f","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_1761c57e466f6136351e8613a41f32baae69703af73cfded579937db417ab98f","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"844be28df03a011da0fc73341cee471fd84ba4728b57748cdde0c4350edb1d3f","published":"Mon, 01 Jun 2026 00:00:00 -0400","receipt_hash":"844be28df03a011da0fc73341cee471fd84ba4728b57748cdde0c4350edb1d3f","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"844be28df03a011da0fc73341cee471fd84ba4728b57748cdde0c4350edb1d3f","observed_at":"2026-06-01T04:43:13.859018Z","parent_run_hash":"8993bbc535dae8c9669e099af3624cb39166b8d9bbfd66f26ae5c338cbb21be2","published":"Mon, 01 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2605.29146v2 Announce Type: replace-cross \nAbstract: Medication recommendation predicts medications for patient visits, but existing methods still face two key challenges. At the model level, traditional drug recommendation methods only predict structured drug codes with limited evidence grounding, while LLM agents can use richer clinical context but may lack safety verification and traceability. At the task level, existing benchmarks often use broad medication categories, which ignore subgroup-level safety differences and can lead to risk overestimation. We introduce the first fine-grained medication recommendation setting based on fourth-level ATC code generation. We propose Safe Prescription Agent (SafeRx-Agent), a knowledge-grounded multi-agent framework that uses patient context, external clinical knowledge, and safety verification to recommend traceable medication sets. Experimental results on MIMIC-III and MIMIC-IV datasets show that SafeRx-Agent improves fine-grained medi","title":"SafeRx-Agent: A Knowledge-Grounded Multi-Agent Framework for Safe and Explainable Medication Recommendation","url":"https://arxiv.org/abs/2605.29146","vendor":"arxiv_cs_ai"},"summary":"arXiv:2605.29146v2 Announce Type: replace-cross \nAbstract: Medication recommendation predicts medications for patient visits, but existing methods still face two key challenges. At the model level, traditional drug recommendation methods only predict structured drug codes with limited evidence grounding, while LLM agents can use richer clinical context but may lack safety verification and traceability. At the task level, existing benchmarks often use broad medication categories, which ignore subgroup-level safety differences and can lead to risk overestimation. We introduce the first fine-grained medication recommendation setting based on fourth-level ATC code generation. We propose Safe Prescription Agent (SafeRx-Agent), a knowledge-grounded multi-agent framework that uses patient context, external clinical knowledge, and safety verification to recommend traceable medication sets. Experimental results on MIMIC-III and MIMIC-IV datasets show that SafeRx-Agent improves fine-grained medi","title":"SafeRx-Agent: A Knowledge-Grounded Multi-Agent Framework for Safe and Explainable Medication Recommendation","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-01T04:43:13Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2605.29146"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:454d2711e4a2ce58a71010d9c4dc4e56d9cae975a6555618ef73a7280e18004a09e3ecd35dc1cc4c8ee0947cce9f0095ae5c06944aa049a40311100f2a86a80c","signer":"crovia.substrate","subject":{"observed_at":"2026-06-01T04:43:13Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2605.29146"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"9000c37975c23a4ed727a05848ff8e8d5923c4ef202cdb29fcbd4b5a7d2d50a7","leaf_index":164163,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"22f277cc43f0bae70a8a1599d1458d7cecab4c8d686f5fa7c989cad5a252dcea","side":"left"},{"sibling":"1c986cdf415383bc476bec775eedfc43db7fae270f75a53ae7b66e8fe0728462","side":"left"},{"sibling":"8f13cd906c8bb80a5315887d58971b303920241cd6750fd2c85f67894d5cd29f","side":"right"},{"sibling":"fc2431a35da0ada750108a1f573afc375508573e064be3197d4dae6c60e0dce6","side":"right"},{"sibling":"4c96556e00e265a423aed6dd4e5d78300358244717099b23ae7fb4764f798213","side":"right"},{"sibling":"f349a41246b4f4546bf46f61e651e243606f532110111109bb51fbda889ed5b2","side":"right"},{"sibling":"ef51d11b8205c01a52d9dcd3705d517a51f2304f019bc0e097c1931e8170c346","side":"left"},{"sibling":"fa66353dd6f42c595db53c4b87c558d4cbcc04862c4058c0562cc7d5d9015f15","side":"right"},{"sibling":"7caaac9d7d329e12cd7433a2a627fcb2eaa744feb44b4a8462db35186e31e111","side":"left"},{"sibling":"fc601f0745c37fc5f7c249300e654db05d61bb9059885eeb0b0a5047b5d28408","side":"right"},{"sibling":"6ed9290cdae063f13bfeb71c4c5440595cabb61fd4b39225b9cc913ffb336dd7","side":"right"},{"sibling":"a0446b923d1ce90021e78edff07f6bfc7cc2a1326a565c5f0786b82a24dd0a2a","side":"right"},{"sibling":"e598fd53912c30e58ca8e58d7d8a338fe0f2ecb63fdd99225bc703c499c948ec","side":"right"},{"sibling":"fc4873333221ec8167697f75b6f6a8a08491a8cf18952defb65fb6d4958fa5e7","side":"right"},{"sibling":"05c8a827da2a05549ee3250310777009120c687885816bf6c7c74801bfaa346d","side":"right"},{"sibling":"5ea2f2dc9f046df723b6bd9932d61a9a3d80a76e79ce1b939b3d93ff79b5a91c","side":"left"},{"sibling":"ce41d9b82f34b16efd653dfb3552acc4e2512939e47903e5fc979fbed00c5764","side":"right"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":164217,"merkle_root":"a1098816aea1b60b8fe37b62410469bc5024a2c335bbec4f6ef2add7875dbdf2","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260601T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-01T05:37:41Z","sig_algorithm":"ed25519","signature":"d7f91db1d54b9495c499440c2828f4bd53360555391ce6e25adea5183bc1fa0f697d80708a099d0b0429e6f8cb6c71e7fccf82acb3c84481149974fb26074708","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_1761c57e466f6136351e8613a41f32baae69703af73cfded579937db417ab98f"}}